Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Total 13F shares
-
22,941,416
-
Share change
-
+5,248,514
-
Total reported value
-
$139,523,457
-
Price per share
-
$6.08
-
Number of holders
-
65
-
Value change
-
+$32,049,269
-
Number of buys
-
27
-
Number of sells
-
35
Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) as of Q3 2020
As of 30 Sep 2020,
Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,941,416 shares.
The largest 10 holders included
Slate Path Capital LP, EcoR1 Capital, LLC, FMR LLC, MFN Partners Management, LP, Artal Group S.A., VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.